HCA Healthcare, Inc. (HCA) Financials
Annual revenue, profitability and per-share results for HCA Healthcare, Inc., as reported in SEC filings.
Revenue • FY2025
$75.6B
▲ 7.1%YoY
Net income • FY2025
$6.78B
▲ 17.8%YoY
Diluted EPS • FY2025
$28.33
▲ 28.8%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $75.6B | $6.78B | — | $28.33 | $7.69B | — | +7.1% |
| FY2024 | $70.6B | $5.76B | — | $22.00 | $5.64B | — | +8.7% |
| FY2023 | $64.97B | $5.24B | — | $18.97 | $4.69B | — | +7.9% |
| FY2022 | $60.23B | $5.64B | — | $19.15 | $4.13B | — | +2.5% |
Figures as reported in HCA Healthcare, Inc.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a HCA filing.
Get an email when HCA files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.